The ZosterFluCOV study is a collaboration between the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust and it is being run by the Bristol Trials Centre. The study is looking at the safety, as well as the immune responses, when giving the currently approved shingles vaccine (Shingrix) at the same time as either a COVID-19 booster or the influenza (flu) vaccines from the 2022/2023 and 2024/25 NHS vaccination programme.
This study is Sponsored by University Hospitals Bristol and Weston NHS Foundation Trust (Chief Investigator Dr Rajeka Lazarus). The study is funded by GlaxoSmithKline Ltd (GSK).